MedWatch

Bioporto boss: "The corona crisis required good old-fashioned leadership"

Above all else, the corona pandemic highlighted the crucial need for clear communication and strong leadership, says Bioporto CEO Peter Mørch. He has told his employees about his plans along the way to help them feel safe - and all employees are now back at their offices in Denmark.

CEO Peter Mørch, Bioporto. | Foto: Bioporto/ PR

As the coronavirus spread across more and more of the world, Danish diagnostics business Bioporto encountered more and more challenges. The company had 10 clinical studies underway at US hospitals, but they were shut down, and the FDA approval that was expected has been delayed again.

Bioporto's US sales organization was cut down to the bone. It became impossible to get access to Danish hospitals, and CEO Peter Mørch was forced to cancel his business trips.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Biontech-direktører: Derfor måtte Afrika vente på coronavacciner

Tyske Biontech vil bruge de mange corona-milliarder på at hjælpe lande i Afrika med at komme både coronavirus, malaria og turberkulose til livs, men alligevel stod kontinentet langt nede i køen, da de første coronavacciner skulle distribueres. MedWatch har spurgt hvorfor.

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier